跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 381 条关于
“Waldenström Macroglobulinemia”
全部
381
临床试验
333
药物
1
机构
0
资讯
47
去年
Iopofosine I 131 Shows Promise in Heavily Pretreated Waldenström Macroglobulinemia
去年
Schrödinger's SGR-1505 Receives FDA Fast Track Designation for Relapsed Waldenström Macroglobulinemia
2年前
Iopofosine I-131 Demonstrates Promising Results in Relapsed/Refractory Waldenström Macroglobulinemia
去年
NX-5948 Demonstrates Promising Activity in Relapsed/Refractory Waldenström Macroglobulinemia
去年
Breakthrough Developments in Waldenström Macroglobulinemia Treatment: BTK Inhibitors and Novel Therapies Show Promise
10个月前
Switching from Ibrutinib to Zanubrutinib Maintains Efficacy and Safety in Waldenström Macroglobulinemia Patients
9天前
Waldenström Macroglobulinemia Market Poised for Steady Growth Through 2036 on Novel BTK Degraders, Non-Covalent BTKis, and Targeted Radiotherapeutics
2年前
AI Platform CURATE.AI Shows Promise in Treating Rare Cancer, Waldenström Macroglobulinemia
去年
BGB-16673 Shows Promise in Relapsed/Refractory CLL/SLL and Waldenström Macroglobulinemia
去年
Cellectar Biosciences' Iopofosine I 131 Shows Promise in Waldenstrom's Macroglobulinemia
第 1 页，共 5 页
上一页
下一页
